These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28943980)

  • 1. Physician-pharmacist agreement about off-label use of medications in private clinical settings in Baghdad, Iraq.
    Hussain SA; Abbas AN; Alhadad HA; Al-Jumaili AA; Abdulrahman ZS
    Pharm Pract (Granada); 2017; 15(3):979. PubMed ID: 28943980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of perceived impact on relationship quality in pharmacists' willingness to influence indication-based off-label prescribing decisions.
    Basak R; Bentley JP; McCaffrey DJ; Bouldin AS; Banahan BF
    Soc Sci Med; 2015 May; 132():181-9. PubMed ID: 25818379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital pharmacists' perceived beliefs and responsibilities in indication-based off-label prescribing.
    Basak R; McCaffrey DJ
    Int J Clin Pharm; 2018 Feb; 40(1):36-40. PubMed ID: 29204800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing the degree of physician-pharmacist collaboration within Iraqi public healthcare settings.
    Al-Jumaili AA; Al-Rekabi MD; Doucette W; Hussein AH; Abbas HK; Hussein FH
    Int J Pharm Pract; 2017 Dec; 25(6):411-417. PubMed ID: 28181318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Awareness, Practice, and Views of Pediatricians, General Physicians, and Pharmacists about Prescribing Off-label Medication in Pediatric Patients in Eastern Province, Saudi Arabia.
    Almintakh LS; Al Dossary MF; Altesha AM; Alqahtani RF; Alsomali SM; Banu N; Ali MD; Ahmed A
    Curr Pediatr Rev; 2024 Jun; ():. PubMed ID: 38934287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitudes and experiences of community pharmacists towards paediatric off-label prescribing: a prospective survey.
    Stewart D; Rouf A; Snaith A; Elliott K; Helms PJ; McLay JS
    Br J Clin Pharmacol; 2007 Jul; 64(1):90-5. PubMed ID: 17324238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On-the-ground application of the 'temporary recommendation for use' regulatory measure on off-label use of baclofen for alcohol dependence in France: a regional survey of community pharmacies.
    Auffret M; Rolland B; Caous AS; Gaboriau L; Deheul S; Bordet R; Gautier S
    Fundam Clin Pharmacol; 2018 Apr; 32(2):234-238. PubMed ID: 29143356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system.
    Wong J; Motulsky A; Abrahamowicz M; Eguale T; Buckeridge DL; Tamblyn R
    BMJ; 2017 Feb; 356():j603. PubMed ID: 28228380
    [No Abstract]   [Full Text] [Related]  

  • 9. Off-label prescription: developing a guideline and validating an instrument to measure physicians' and clinical pharmacists' knowledge and attitudes toward off-label medication use.
    Salari P; Larijani B; Zahedi F; Noroozi M
    J Diabetes Metab Disord; 2023 Dec; 22(2):1599-1608. PubMed ID: 37975085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of pharmacists' interventions on physicians' decision of a knowledge-based renal dosage adjustment system.
    Choi KS; Lee E; Rhie SJ
    Int J Clin Pharm; 2019 Apr; 41(2):424-433. PubMed ID: 30864079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pharmacists' clinical interventions on nonformulary drug use.
    Packer LA; Mahoney CD; Rich DS; Jeffrey LP
    Am J Hosp Pharm; 1986 Jun; 43(6):1461-6. PubMed ID: 3728481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug, patient, and physician characteristics associated with off-label prescribing in primary care.
    Eguale T; Buckeridge DL; Winslade NE; Benedetti A; Hanley JA; Tamblyn R
    Arch Intern Med; 2012 May; 172(10):781-8. PubMed ID: 22507695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of pharmacist-physician collaboration in psychiatry: 'the Eichberger-model'.
    Hahn M; Ritter C; Roll SC
    Int J Clin Pharm; 2018 Oct; 40(5):1001-1004. PubMed ID: 29796963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Off-label approval of drug use in a tertiary hospital].
    Pérez-Moreno MA; Villalba-Moreno AM; Santos-Ramos B; Marín-Gil R; Varela-Aguilar JM; Torelló-Iserte J; Núñez-Vázquez R; Jiménez-Jiménez J; Bautista-Paloma FJ
    Rev Calid Asist; 2013; 28(1):12-8. PubMed ID: 22789731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Descriptive review and analysis of immunoglobulin utilization management from 2,548 prior authorization requests.
    Tonkovic B; Rutishauser LK
    J Manag Care Spec Pharm; 2014 Apr; 20(4):357-67. PubMed ID: 24684640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized Study of Providing Evidence Context to Mitigate Physician Misinterpretation Arising From Off-Label Drug Promotion.
    Schwartz LM; Woloshin S; Lu Z; Ross KM; Tessema FA; Peter D; Kesselheim AS
    Circ Cardiovasc Qual Outcomes; 2019 Nov; 12(11):e006073. PubMed ID: 31707825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Off-label prescription of drugs at hospital.
    Arocas Casañ V; Mateo Carmona J; García Molina O; Fernández de Palencia Espinosa MÁ; Blázquez Álvarez MJ; de la Rubia Nieto MA; del Río García J
    Farm Hosp; 2016 Mar; 40(2):63-71. PubMed ID: 26980165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community pharmacist-led clinical services: physician's understanding, perceptions and readiness to collaborate in a Midwestern state in the United States.
    Gordon C; Unni E; Montuoro J; Ogborn DB
    Int J Pharm Pract; 2018 Oct; 26(5):407-413. PubMed ID: 29218803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Off-label prescribing patterns of antidepressants in children and adolescents.
    Lee E; Teschemaker AR; Johann-Liang R; Bazemore G; Yoon M; Shim KS; Daniel M; Pittman J; Wutoh AK
    Pharmacoepidemiol Drug Saf; 2012 Feb; 21(2):137-44. PubMed ID: 21538674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On-label and off-label prescribing patterns of erythropoiesis-stimulating agents in inpatient hospital settings in the US during the period of major regulatory changes.
    Seetasith A; Holdford D; Shah A; Patterson J
    Res Social Adm Pharm; 2017; 13(4):778-788. PubMed ID: 27595426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.